Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain

The inability of most drugs to cross the blood-brain barrier and/or plasma membrane limits their use for biomedical applications in the brain. Cell Permeable Peptides (CPPs) overcome this problem and are effective in vivo, crossing the plasma membrane and the blood-brain barrier. CPPs deliver a wide variety of compounds intracellularly in an active form. In fact, many bioactive cargoes have neuroprotective properties, and due to their ability to block protein-protein interactions, offer exciting perspectives in the clinical setting. In this review we give an overview of the Cell Permeable Peptides strategy to deliver neuroprotectants against neurodegeneration in the CNS.

Abstract licence: CC BY

40 more references, whose wording the paper’s licence keeps private.

• DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives · 2019

• Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets · 2019

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.